Our results suggest that the targeted form of IL-27 may be utilized as a strategy impacting cell translation initiation through modulating the eIF2α pathway (stress to the endoplasmic reticulum (ER) leading to apoptosis) as a novel approach for treating prostate cancer. The gene discussed is EIF2A; the disease is prostate cancer.